Paul H. Klingenstein is Director at EnteroMedics Inc (ETRM). They have made 9 open-market trades across 4 companies since 2007, most recently 2019-07-29.
CIK 0000935463
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
8 open-market purchases totalling $11.9M since 2007, against 1 sale. Across 7 scored buys the stock is down 8.1% at ninety days, and 8.4 points behind the S&P over the same stretch.
7 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 0% | 14% | 14% |
| Avg Move | -37.7% | -8.1% | -8.1% |
| Alpha | -31.9% | -8.4% | -8.4% |
| Scored | 7 | 7 | 7 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| CNAT | BUY | 2013-07-30 | 2013-08-01 | $11.00 | $1.2M | N/A | N/A | N/A |
| CNAT | SELL | 2013-07-30 | 2013-08-01 | $11.00 | $6K | N/A | N/A | N/A |
| CLVS | BUY | 2011-11-21 | 2012-03-22 | $13.00 | $5.2M | -29.4% | -2.5% | -2.5% |
| ANAC | BUY | 2010-11-30 | 2010-12-01 | $5.00 | $1.5M | -19.4% | +2.3% | +2.3% |
| ETRM | BUY | 2009-02-24 | 2009-02-25 | $1.15 | $1.4M | -43.0% | -11.4% | -11.4% |
| ETRM | BUY | 2008-05-29 | 2008-06-03 | $4.50 | $207K | -43.0% | -11.4% | -11.4% |
| ETRM | BUY | 2008-05-23 | 2008-05-28 | $4.50 | $113K | -43.0% | -11.4% | -11.4% |
| ETRM | BUY | 2008-05-19 | 2008-05-21 | $4.77 | $239K | -43.0% | -11.4% | -11.4% |
| ETRM | BUY | 2007-11-15 | 2007-11-19 | $8.00 | $2.0M | -43.0% | -11.4% | -11.4% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.